Pacira Pharmaceuticals, Inc - PCRX

38.2200
USD -8.9300 (-0.1894%)
Volume: 539,900
Trade

Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and commercializes proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company’s lead product includes, EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.

Trade Pacira Pharmaceuticals, Inc at these brokers
1 2 3 4 5 6 7 8 9 10
3.75
  • Platforms: Andriod App, iOS App, Mobile App, WebTrader
  • License: Not Applicable
Your capital is at risk
1 2 3 4 5 6 7 8 9 10
3.75
  • Platforms: Andriod App, Apple App, iOS App, MetaTrader 4, MetaTrader 5, Mobile App, Proprietary, WebTrader
  • License: CySEC, FCA UK
Your capital is at risk
1 2 3 4 5 6 7 8 9 10
4.5
  • Platforms: Andriod App, Apple App, iOS App, Mobile App, WebTrader
  • License: ASIC, CySEC, FCA UK
Your capital is at risk